Year None20222021202020192018 July 25, 2022 - Ginkgo to Acquire Zymergen PDF Version July 14, 2022 - Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform PDF Version June 28, 2022 - Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications PDF Version May 26, 2022 - Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform PDF Version May 12, 2022 - Zymergen Reports Preliminary First Quarter 2022 Financial Results PDF Version April 29, 2022 - Zymergen to Participate in the BofA Securities 2022 Healthcare Conference PDF Version April 13, 2022 - Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022 PDF Version March 22, 2022 - Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results PDF Version March 16, 2022 - Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022 PDF Version March 6, 2022 - Zymergen Advances Molecules for Prominent Malaria and COVID-19 Drug Targets for Further Testing PDF Version Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 14
July 14, 2022 - Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform PDF Version
June 28, 2022 - Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications PDF Version
May 26, 2022 - Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform PDF Version
April 29, 2022 - Zymergen to Participate in the BofA Securities 2022 Healthcare Conference PDF Version
April 13, 2022 - Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022 PDF Version
March 22, 2022 - Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results PDF Version
March 16, 2022 - Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022 PDF Version
March 6, 2022 - Zymergen Advances Molecules for Prominent Malaria and COVID-19 Drug Targets for Further Testing PDF Version
